Department of Endocrinology, the First Hospital Affiliated to China Medical University, Shenyang, Liaoning, China.
Division of Endocrinology, Shenyang NO.8 hospital, Shenyang, Liaoning, China.
Diabetes Metab Res Rev. 2016 Sep;32(6):534-43. doi: 10.1002/dmrr.2788. Epub 2016 Apr 21.
Silent information regulator 1 (Sirt1) plays a protective role in kidney. Sirt1 suppresses activation of hypoxia-inducible factor-1 alpha (HIF-1α), with MircroRNA-217 (Mir-217) being closely related to Sirt1. The relationship of Sirt1, HIF-1α and Mir-217, however, has never been reported in high glucose cultured rat glomerular mesangial cells (RMCs). Thus, we explored the role of Mir-217 on inflammation and fibrosis in RMCs cultured with high glucose in vitro through Sirt1/HIF-1α signaling pathway.
Rat glomerular mesangial cells were pre-incubated with Sirt1 activator Resveratrol prior to high glucose treatment. Furthermore the cells were transiently transfected with Sirt1 small interfering RNA (siRNA), HIF-1α siRNA and Mir-217 inhibitor using Lipofectamine 2000. Real-time PCR was used to analyse the expression of Mir-217, Sirt1 mRNA and HIF-1α mRNA; Western Blot was used to observe protein expression of Sirt1, HIF-1α, connective tissue growth factor, endothelin-1 and fibronectin; enzyme-linked immunosorbent assay was used to detect protein expression of transforming growth factor-β1 and vascular endothelial growth factor.
High glucose increased Mir-217 expression. High glucose decreased Sirt1 expression, accompanied by the increased HIF-1α expression and then promoted inflammation and fibrosis. In addition, Mir-217 gene silencing or Resveratrol could suppress the expression of HIF-1α, which in turn restrained inflammation and fibrosis in rat glomerular mesangial cells cultured with high glucose.
This study clarified the role of Mir-217 in high glucose cultured rat glomerular mesangial cells through Sirt1/HIF-1α signaling pathway and provided new therapeutic targets for diabetic nephropathy. Copyright © 2016 John Wiley & Sons, Ltd.
沉默信息调节因子 1(Sirt1)在肾脏中发挥保护作用。Sirt1 抑制缺氧诱导因子-1α(HIF-1α)的激活,而 MircroRNA-217(Mir-217)与 Sirt1 密切相关。然而,在高糖培养的大鼠肾小球系膜细胞(RMC)中,Sirt1、HIF-1α 和 Mir-217 之间的关系尚未报道。因此,我们通过 Sirt1/HIF-1α 信号通路探讨了 Mir-217 在体外高糖培养的 RMC 炎症和纤维化中的作用。
用 Sirt1 激活剂白藜芦醇预先孵育大鼠肾小球系膜细胞,然后用脂质体 2000 将 Sirt1 小干扰 RNA(siRNA)、HIF-1α siRNA 和 Mir-217 抑制剂瞬时转染细胞。实时 PCR 用于分析 Mir-217、Sirt1 mRNA 和 HIF-1α mRNA 的表达;Western Blot 用于观察 Sirt1、HIF-1α、结缔组织生长因子、内皮素-1 和纤维连接蛋白的蛋白表达;酶联免疫吸附试验用于检测转化生长因子-β1 和血管内皮生长因子的蛋白表达。
高糖增加了 Mir-217 的表达。高糖降低了 Sirt1 的表达,同时伴随着 HIF-1α 的表达增加,进而促进了炎症和纤维化。此外,Mir-217 基因沉默或白藜芦醇可以抑制 HIF-1α 的表达,从而抑制高糖培养的大鼠肾小球系膜细胞的炎症和纤维化。
本研究通过 Sirt1/HIF-1α 信号通路阐明了 Mir-217 在高糖培养的大鼠肾小球系膜细胞中的作用,为糖尿病肾病提供了新的治疗靶点。版权所有©2016 约翰威立父子公司